Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a string of drugmakers pledging to increase U.S. capacity amid Trump ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Lots on the table today about AI-driven drug discovery, including some ...

The drug maker on Tuesday announced a new 470,000-square-foot facility in Wilmington, Delaware, where it will make Keytruda, the company's immunotherapy treatment for different cancers. The plant ...

Multi-drug antibiotic-resistance is one ... maltophilia for biotech applications designed to increase plant growth. “The work in our lab is presently concentrating on two other plant-growth ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

He co-founded a biotech company called Variant Bio that has cut revenue-sharing deals with more than 25 Indigenous groups around the world to use their genomes to discover new targets for drugs.

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't been possible to do it biosynthetically. Until now, that is. Researchers ...

The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...